leukotoxin has been researched along with Leukemia* in 4 studies
4 other study(ies) available for leukotoxin and Leukemia
Article | Year |
---|---|
In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Leukotoxin (Leukothera™; LtxA) is a bacterial protein and experimental therapeutic that binds leukocyte function antigen (LFA-1) on white blood cells (WBCs) and induces cell death via apoptosis or necrosis. We previously found that LtxA preferentially targets WBCs with high levels of activated LFA-1, which is characteristic of many leukemias and lymphomas, and showed that LtxA exhibits significant anti-leukemia activity in vivo using the humanized SCID mouse model. In this report, we demonstrate that LtxA induces very rapid (1h) apoptosis in acute monocytic leukemia THP-1 cells characterized by binding of annexin V to cells, loss of mitochondrial membrane potential, depletion of cellular ATP, and fragmentation of chromosomal DNA. We tested the activity of LtxA in combination with the standard chemotherapeutic agents, etoposide, mitoxantrone, daunorubicin, busulfan, and imatinib against several leukemia cell lines, including THP-1, GDM-1, HL-60, and KU-812 cells. LtxA exhibited synergism with all the drugs, and the levels of synergy were dependent on the doses used and cell lines examined. In general, the greatest level of synergy was observed with LtxA and etoposide or imatinib. Combination index (CI) values were less than 0.1 for many of the combinations, indicating very strong synergism. In addition, LtxA alone was cytotoxic to primary cells from newly diagnosed, relapsed, and refractory patients with different hematological malignancies. Thus, LtxA is highly effective at inducing rapid apoptosis both as a single agent and in combination with approved leukemia therapies. Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Busulfan; Cell Line, Tumor; Daunorubicin; Drug Interactions; Drug Synergism; Etoposide; Exotoxins; Flow Cytometry; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia; Leukocytes; Lymphocyte Function-Associated Antigen-1; Membrane Potential, Mitochondrial; Mitoxantrone; Piperazines; Pyrimidines; Tumor Cells, Cultured | 2011 |
Synergistic targeting of leukemia with leukotoxin and chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Exotoxins; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Function-Associated Antigen-1 | 2011 |
Destroying malignant white cells.
Topics: Animals; Antineoplastic Agents; Bacterial Toxins; Cell Line, Tumor; Cytotoxins; Exotoxins; Hematologic Neoplasms; Leukemia; Mice | 2008 |
pH dependent alterations of monoepoxides and monochlorohydrins of linoleic acid, and their existence in vivo.
Some monoepoxides of linoleic acid (LA) were converted to monochlorohydrins in low-pH solutions containing chloride ions (Cl-). Conversely, monochlorohydrins of LA were converted to monoepoxides in high-pH solutions. We attempted to determine whether these monochlorohydrins and monoepoxides were produced from LA by the cytochrome-c-H2O2-and/or myeloperoxidase-H2O2-system. The existence of monoepoxides and monochlorohydrins of LA in leukocytes was confirmed by high-performance liquid chromatography (HPLC). Furthermore, leukotoxin in human leukemia cells (THP-1) was stained immunohistochemically by a monoclonal anti-leukotoxin antibody. Topics: Animals; Cell Line; Chlorohydrins; Chromatography, High Pressure Liquid; Cytochrome c Group; Epoxy Compounds; Exotoxins; Exudates and Transudates; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Leukemia; Leukocytes; Linoleic Acid; Linoleic Acids; Male; Mass Spectrometry; Peroxidase; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1995 |